SASamuhaer Azhati

Samuhaer Azhati

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samuhaer Azhati has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Syringaresinol activates the skeletal muscle SIRT1–FNDC5/irisin axis to enhance weight management

    by Shuning Liu, Fang Zhao, Samuhaer Azhati, Wei Shan, Biaoxu Tao, Wen Zhong, Yan Wei, Wei Jiang, Kai Zhao, Chang Liu

    This study examined whether syringaresinol (SYR), a plant-derived lignan, modulates skeletal muscle SIRT1-related FNDC5/Irisin signaling and high-fat diet (HFD)-associated metabolic outcomes. Differentiated C2C12 myotubes were treated with SYR, the SIRT1 activator SRT1720, and the SIRT1 inhibitor EX-527 to assess Irisin-related readouts, mitochondrial-associated markers, gene expression, and SIRT1/PGC-1α protein abundance. In vivo, HFD-fed mice received low- or high-dose SYR by oral gavage for 18 weeks; body weight, food intake, plasma Irisin, lipid-related indices, and adipose-tissue gene expression were assessed. In C2C12 myotubes, SYR was associated with increased Irisin-related readouts, ATP content, citrate synthase activity, SIRT1/PGC-1α/FNDC5-related transcriptional changes, and higher SIRT1 and PGC-1α protein abundance. EX-527 attenuated SYR-associated responses, supporting involvement of SIRT1 signaling in the cellular model. In HFD-fed mice, SYR attenuated body-weight gain, increased circulating plasma Irisin, lowered the LDL-C/HDL-C ratio, and increased PGC-1α, Ucp1, and Pparγ expression in inguinal white adipose tissue without significantly changing food intake. SYR is associated with SIRT1/PGC-1α-related remodeling, Irisin-related readouts, and attenuated HFD-induced weight gain. These findings support SYR as a candidate nutritional modulator of muscle–adipose metabolic communication, while causal in vivo mediation by SIRT1, FNDC5, or Irisin requires further pathway-specific validation.

  • Open Access

    Global, regional, and national burden of lower-limb fractures, 1990 to 2021, with health inequalities and projections to 2040: An observational analysis of Global Burden of Disease Study 2021 data

    by Samuhaer Azhati, Shuning Liu, Zhongxu Hu, Kai Zhao, Dixin Zou, Yan Wei, Yutong Wu, Yue Dou, Wei Jiang, Chang Liu

    Lower-limb fractures are important contributors to disability worldwide, but their long-term burden, Sociodemographic Index (SDI)-related inequalities, and future trajectories remain incompletely characterized. This study assessed the global, regional, and national burden of lower-limb fractures from 1990 to 2021 and projected trends to 2040 using data from the Global Burden of Disease Study 2021. Data on years lived with disability due to lower-limb fractures were obtained from the Global Burden of Disease Study 2021 for 204 countries and territories. Four anatomical subtypes were analyzed: fracture of the hip (FH); fracture of the patella, tibia, fibula, or ankle (FPTFA); fracture of the foot bones excluding the ankle (FFB); and fracture of the femur excluding the femoral neck (FF). Age-standardized rates (ASRs) and YLD numbers were assessed by sex, age, year, location, and SDI. Joinpoint regression, decomposition analysis, the Slope Index of Inequality, Concentration Index, and Bayesian age-period-cohort models were used to evaluate temporal trends, drivers of absolute burden, SDI-related inequalities, and projections to 2040. In 2021, FPTFA had the largest global YLD burden, with 16.58 million years lived with disability, followed by FH with 3.10 million, FF with 1.18 million, and FFB with 0.41 million. From 1990 to 2021, global YLD numbers increased for all 4 subtypes, by 75.2% for FH, 43.0% for FPTFA, 35.5% for FFB, and 56.7% for FF. In contrast, global ASRs declined by 19.7%, 23.1%, 26.5%, and 18.2%, respectively. Slope Index of Inequality values decreased across all subtypes, indicating narrowing absolute SDI-related differences, whereas Concentration Index values changed less markedly, suggesting persistent relative distributional inequality. Joinpoint regression showed declining global ASRs, with average annual percentage changes of −0.71 for FH, −0.83 for FPTFA, −0.99 for FFB, and −0.65 for FF. Bayesian age-period-cohort projections suggested broadly stable or slightly declining global ASRs through 2040, with sex-specific patterns differing by subtype. Although global ASRs for lower-limb fracture-related disability declined from 1990 to 2021, the absolute YLD burden increased across all 4 subtypes. These findings support subtype- and context-specific strategies, including osteoporosis management, fall prevention, fracture liaison services, and rehabilitation in aging high-SDI settings, alongside strengthened trauma care, timely orthopedic treatment, rehabilitation, and financial protection in lower-SDI settings.

  • Open Access

    Low Back Pain in Chinese Adults Aged 45 Years and Older: Trends, Drivers, and Projections, 1990–2040

    by Samuhaer Azhati, Shuning Liu, Ruizhe Song, Mingchen Li, Yan Wei, Chang Liu, Huaichuan Zhang

    Background: Low back pain (LBP) is a major cause of disability in later life. We aimed to assess the population-level burden, demographic and epidemiological drivers, GBD-defined risk attribution, and future trajectory of LBP among Chinese adults aged 45 years and older. Methods: Using population-level estimates from the Global Burden of Disease Study 2023 (GBD 2023), we analyzed incidence, prevalence, and years lived with disability (YLDs) among Chinese adults aged 45 years and older from 1990 to 2023. We assessed temporal trends, decomposed changes in burden, evaluated age–period–cohort patterns, quantified YLDs attributable to three GBD-defined risk factors—high body mass index, occupational ergonomic factors, and smoking—and projected burden to 2040 using Bayesian age–period–cohort models. Results: In 2023, population-level GBD estimates indicated that LBP accounted for 30.29 million incident cases, 71.54 million prevalent cases, and 7.90 million YLDs among Chinese adults aged 45 years and older. Compared with 1990, these numbers increased by 101.54%, 97.08%, and 96.11%, respectively, despite declining age-restricted age-standardized incidence, prevalence, and YLD rates. Expansion of the population aged 45 years and older was the main driver of the increasing absolute burden, whereas favorable epidemiological change offset part of this increase. High body-mass index showed the largest increase in attributable burden and was the only risk factor with rising age-standardized attributable YLD rates. Model-based projections suggested that age-restricted age-standardized burden would continue to decline through 2040. Conclusions: LBP remains a growing absolute burden among middle-aged and older adults in China despite declining age-restricted age-standardized rates. Future disability reduction will require integrated strategies combining risk-factor control, rehabilitation, functional support, and age-sensitive care.


  • Open Access

    The Effects of Astaxanthin Supplementation on Exercise Recovery Biomarkers and Exercise Performance: A Systematic Review and Meta-Analysis

    by Shuning Liu, Wenqian Yao, Yan Wei, Samuhaer Azhati, Yutong Wu, Wen Zhong, Pengda Wang, Heping Dai, Kai Zhao, Chang Liu

    Background: Astaxanthin is a lipid-soluble carotenoid with antioxidant and anti-inflammatory properties, but its effects on exercise performance and post-exercise recovery remain uncertain. This systematic review and meta-analysis aimed to evaluate the effects of astaxanthin supplementation on exercise performance and recovery-related biomarkers in healthy participants and athletes. Methods: This review followed PRISMA 2020 guidelines. PubMed, Web of Science, Embase, EBSCO, the Cochrane Library, and CNKI were searched from inception to January 2026. Randomized controlled trials comparing oral astaxanthin supplementation with placebo or control were included. Performance outcomes included VO2max, time-trial or endurance-related performance, and maximal workload or power output. Recovery-related outcomes included creatine kinase, lactate dehydrogenase, malondialdehyde, interleukin-6, and related biomarkers. Standardized mean differences with 95% confidence intervals were pooled. Results: Twenty-four RCTs were included. Astaxanthin significantly reduced creatine kinase levels (SMD = −0.45, 95% CI: −0.83 to −0.07). Lactate dehydrogenase also favored astaxanthin (SMD = −0.93, 95% CI: −1.39 to −0.48), although heterogeneity was substantial. No significant effects were observed for malondialdehyde or interleukin-6. Astaxanthin did not significantly improve VO2max, time-trial performance, or maximal workload/power output. Conclusions: Current evidence suggests that astaxanthin may be more beneficial for post-exercise recovery than for direct performance enhancement. The most consistent effect was observed for creatine kinase, whereas the LDH finding should be interpreted cautiously. Further well-powered trials with standardized dosing, duration, exercise protocols, and outcome assessments are needed.


  • Open Access

    The Effects of Seaweed and Microalgae Supplementation on Exercise Performance and Recovery: A Systematic Review and Meta-Analysis

    by Yan Wei, Shuning Liu, Ting You, Xingyu Liu, Wen Zhong, Yutong Wu, Samuhaer Azhati, Qisen Han, Wei Jiang, Chang Liu

    Objective: Seaweed and microalgae provide antioxidants, polyunsaturated fatty acids, and bioactive compounds that may enhance exercise performance and accelerate recovery. However, evidence remains inconsistent. This systematic review and meta-analysis aimed to evaluate the effects of algae-derived supplementation on exercise performance and physiological recovery outcomes in healthy and athletic adults. Methods: This review was registered in PROSPERO (CRD420251166723) and conducted in accordance with PRISMA 2020 guidelines. PubMed, Web of Science, Embase, Cochrane Library, EBSCO, and CNKI were systematically searched for randomized controlled trials (RCTs) evaluating algae supplementation in exercise contexts. Inclusion and exclusion criteria were defined based on the PICOS framework. Primary outcomes included VO2max, Time to exhaustion (TTE), maximal power output (WRmax), Time-Trial (TT) performance, and creatine kinase (CK). Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup, sensitivity, and publication bias analyses were performed. Results: Twenty-two RCTs (n = 822) investigating Spirulina, Chlorella, brown-algal polysaccharides, or astaxanthin met inclusion criteria. Algae supplementation showed a suggestive improvement in VO2max (SMD = 0.88, 95% CI: 0.00–1.75) and significantly improved in TTE (SMD = 1.06, 95% CI: 0.16–1.96), with smaller effects on WRmax (SMD = 0.29, 95% CI: 0.03–0.55), and no significant benefit for TT performance (SMD = −0.27, 95% CI: −0.74 to 0.21). Regarding recovery, CK concentrations were significantly reduced (SMD = −0.78, 95% CI: −1.28 to −0.28). Subgroup analysis suggested greater effects for Chlorella supplementation, higher dosages, and aerobic training contexts; reductions in muscle-damage markers were more evident following resistance exercise. Sensitivity analyses supported the robustness of the main findings with minimal evidence of publication bias. Conclusions: Algae-derived supplements—particularly Spirulina and Chlorella—may modestly enhance aerobic exercise performance and attenuate exercise-induced muscle damage under certain conditions. Effects appear to depend on algae species, dosing strategies, intervention duration, and training modality. High-quality, multi-center RCTs incorporating mechanistic endpoints are needed to clarify optimal application and to develop athlete-specific recommendations.


  • Open Access

    Replication of the GWAS-Identified GALNT13 rs10196189 Polymorphism in Relation to Speed–Power Elite Active Athlete Status and Multidimensional Phenotypic Differences in Chinese Han Males: A Pilot Study

    by Lun Chen, Mingrui Wang, Longtianjiao Liu, Xiaoyu Jiang, Zihang Cao, Samuhaer Azhati, Hangyu Chen, Kaixin She, Jinyao Zhu, Ming Chen, et al.

    Background/Objectives: Previous multi-ethnic genome-wide association studies (GWAS) have identified the GALNT13 rs10196189 polymorphism as a potential genetic marker linked to sprint–power performance. However, its relevance in East Asian populations, particularly the Han Chinese, remains untested. This study aimed to replicate the association of rs10196189 with elite sprint–power athlete status in Han Chinese males and examine its potential influence on physical performance traits and tissue-specific gene regulation. Methods: A total of 188 healthy Han Chinese males (49 elite sprint–power athletes and 139 non-athletic controls) were genotyped using the TaqMan assay. Assessments included strength, sprint, jump, anaerobic power, DXA-derived body composition, and muscle ultrasound. Logistic regression and ROC analyses evaluated the predictive value of rs10196189. Linear regression models adjusted for age and BMI tested genotype–phenotype associations. Tissue expression and functional networks were analyzed using GTEx and HumanBase databases. Results: The G allele frequency was significantly higher in athletes (12.2%) than in controls (5.4%, p = 0.042). Dominant and additive models effectively predicted athlete status (OR = 2.53–2.58, p < 0.05). Although most traits showed no significant associations post-correction, medial gastrocnemius thickness showed a nominal association (β = 0.371, p = 0.011). Functional analyses revealed high GALNT13 expression in brain tissue and co-expression networks enriched in synaptic signaling and glycosylation pathways. Conclusions: This is the first study to validate the association of GALNT13 rs10196189 with elite athletic status in Han Chinese males. Findings provide novel population-specific evidence and propose tissue-specific glycosylation and neural mechanisms as pathways linking this variant to sprint–power phenotypes.


  • Open Access

    Molecular Network Analysis and Effector Gene Prioritization of Endurance-Training-Influenced Modulation of Cardiac Aging

    by Mingrui Wang, Samuhaer Azhati, Hangyu Chen, Yanyan Zhang, Lijun Shi

    Background/Objectives: Cardiac aging involves the progressive structural and functional decline of the myocardium. Endurance training is a well-recognized non-pharmacological intervention that counteracts this decline, yet the molecular mechanisms driving exercise-induced cardiac rejuvenation remain inadequately elucidated. This study aimed to identify key effector genes and regulatory pathways by integrating human cardiac aging transcriptomic data with multi-omic exercise response datasets. Methods: A systems biology framework was developed to integrate age-downregulated genes (n = 243) from the GTEx human heart dataset and endurance-exercise-responsive genes (n = 634) from the MoTrPAC mouse dataset. Thirty-seven overlapping genes were identified and subjected to Enrichr for pathway enrichment, KEA3 for kinase analysis, and ChEA3 for transcription factor prediction. Candidate effector genes were ranked using ToppGene and ToppNet, with integrated prioritization via the FLAMES linear scoring algorithm. Results: Pathway enrichment revealed complementary patterns: aging-associated genes were enriched in mitochondrial dysfunction and sarcomere disassembly, while exercise-responsive genes were linked to protein synthesis and lipid metabolism. TTN, PDK family kinases, and EGFR emerged as major upstream regulators. NKX2-5, MYOG, and YBX3 were identified as shared transcription factors. SMPX ranked highest in integrated scoring, showing both functional relevance and network centrality, implying a pivotal role in mechano-metabolic coupling and cardiac stress adaptation. Conclusions: By integrating cardiac aging and exercise-responsive transcriptomes, 37 effector genes were identified as molecular bridges between aging decline and exercise-induced rejuvenation. Aging involved mitochondrial and sarcomeric deterioration, while exercise promoted metabolic and structural remodeling. SMPX ranked highest for its roles in mechano-metabolic coupling and redox balance, with X-inactivation escape suggesting sex-specific relevance. Other top genes (e.g., KLHL31, MYPN, RYR2) form a regulatory network supporting exercise-mediated cardiac protection, offering targets for future validation and therapy.


  • Open Access

    Molecular Network Analysis and Effector Gene Prioritization of Endurance Training–Influenced Modulation of Cardiac Aging

    by Mingrui Wang, Samuhaer Azhati, Hangu Chen, Yanyan Zhang, Lijun Shi

    Background/Objectives: Cardiac aging involves progressive structural and functional decline of the myocardium. Endurance training is a well-recognized non-pharmacological intervention that counteracts this decline, yet the molecular mechanisms driving exercise-induced cardiac rejuvenation remain inadequately elucidated. This study aimed to identify key effector genes and regulatory pathways by integrating human cardiac aging transcriptomic data with multi-omic exercise response datasets. Methods: A systems biology framework was developed to integrate age-downregulated genes (n = 243) from the GTEx human heart dataset and endurance exercise–responsive genes (n = 634) from the MoTrPAC mouse dataset. Thirty-seven overlapping genes were identified and subjected to Enrichr for pathway enrichment, KEA3 for kinase analysis, and ChEA3 for transcription factor prediction. Candidate effector genes were ranked using ToppGene and ToppNet, with integrated prioritization via the FLAMES linear scoring algorithm. Results: Pathway enrichment revealed complementary patterns: aging-associated genes were enriched in mitochondrial dysfunction and sarcomere disassembly, while exercise-responsive genes were linked to protein synthesis and lipid metabolism. TTN, PDK family kinases, and EGFR emerged as major upstream regulators. NKX2-5, MYOG, and YBX3 were identified as shared transcription factors. SMPX ranked highest in integrated scoring, showing both functional relevance and network centrality, implying a pivotal role in mechano-metabolic coupling and cardiac stress adaptation. Conclusions: This integrative analysis identified SMPX as a top effector gene mediating the anti-aging effects of endurance exercise on the heart. These findings enhance mechanistic understanding of exercise-induced cardiac remodeling and provide a foundation for developing exercise-mimetic therapies.